Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Babel Street has appointed John W. Larson as both President and Chief AI Officer, marking a significant expansion of the company’s executive leadership.
A randomized pilot study published in *Pain Physician* compared Pacira BioSciences’ iovera° cryoneurolysis to radiofrequency ablation (RFA) for chronic low back pain (CLBP).
Oncotelic Therapeutics’ 45% joint venture, Sapu Nano, unveiled data at the 2025 San Antonio Breast Cancer Symposium demonstrating its Deciparticle™ nanomedicine platform’s broad formulation capabilities.
BriaCell will present three posters at the San Antonio Breast Cancer Symposium (SABCS) on December 10, 2025, detailing Phase 2 survival data and Phase 3 biomarker data.
